Kanamycin is widely used as a selection mechanism during production of plasmid DNA for vaccines and gene therapy products. This white paper details how the concentration of Kanamycin is reduced during the VGXI downstream purification process.
Home > Kanamycin Concentration Reduction During the VGXI Process